NSE filing, NSE: GLAXO. Summary written from the filing by ALFA Finder's alert engine.
GlaxoSmithKline Pharmaceuticals Ltd: key numbers
- Share price
- ₹2,535.00
- Market cap
- ₹42,944 Cr
- Revenue (annual)
- ₹3,822 Cr
- Net profit (annual)
- ₹1,036 Cr
- P/E (TTM)
- 40.2×Sector 45.9×
- Promoter holding
- 75.00%+0.00% QoQ
- FII holding
- 4.75%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from GlaxoSmithKline Pharmaceuticals Ltd
All →GlaxoSmithKline Pharmaceuticals Board Meeting Date
GlaxoSmithKline Pharmaceuticals Limited will hold a board meeting on 3rd November 2026 to consider and approve its unaudited financial results for the quarter ended 30th September 2026.
GlaxoSmithKline Pharmaceuticals Other Announcement
GlaxoSmithKline Pharmaceuticals Ltd has filed its quarterly shareholding pattern for the quarter ended September 30, 2026, as required by SEBI listing regulations.
GlaxoSmithKline Pharmaceuticals Annual General Meeting
GSK Pharma's postal ballot approved Ms. Natland as NED and Mr. Akshikar's MD re-appointment. Both resolutions cleared with over 99% shareholder support.
GlaxoSmithKline Pharmaceuticals Annual General Meeting
GlaxoSmithKline Pharmaceuticals issued a corrigendum for its August 3, 2026, postal ballot notice, correcting a typographical error in a reported salary figure.
GlaxoSmithKline Pharmaceuticals Price Movement Clarification
GlaxoSmithKline Pharmaceuticals clarified that recent trading volume increases are purely market-driven. The company confirmed all material disclosures have been made according to SEBI regulations.
GlaxoSmithKline Pharmaceuticals Business Update
GlaxoSmithKline Pharmaceuticals received an income tax refund intimation of Rs 4.99 Crore for the assessment year 2025-2026.
- Value
- ₹4.99 Cr
Other management change announcements
All →EPack Prefab Technologies Management Change
EPack Prefab appointed Ms. Khushboo Mishra as Company Secretary and Compliance Officer, effective 2 November 2026. She has over 13 years of experience in corporate governance and capital markets.
Transwarranty Finance Management Change
Transwarranty Finance appointed Sujit Nair as Senior Vice President - Growth and Strategic Initiatives, effective 2 November 2026. He brings over 24 years of banking and fintech experience.
Galaxy Supermarket Management Change
Galaxy Supermarket's board approved re-appointing Pinki Dixit as Whole-time Director for three years from 20 January 2027, subject to shareholder approval. No monetary value is stated.
DOMS Industries Management Change
DOMS Industries' Company Secretary and Compliance Officer, Mitesh Padia, resigned, effective December 31, 2026. He cited an alternate career opportunity.
Innovassynth Technologies (India) Management Change
Innovassynth's board approved re-appointment of Dr. Hardik Joshipura as MD & CEO for three years from February 12, 2027, subject to shareholder approval. The filing is a Regulation 30 senior-appointment disclosure.
- Execution
- February 12, 2027 to February 11, 2030
LKP Securities Management Change
LKP Securities appointed Mr. Pratik M. Doshi as Chief Financial Officer, effective November 2, 2026. The appointment was approved at a board meeting held the same day.